ETCTN 10563: A phase I study of peposertib and liposomal doxorubicin for advanced or metastatic leiomyosarcoma and other sarcomas.

Authors: Candace L. Haddox, Karla V. Ballman, Elise F. Nassif Haddad, Scott Michael Schuetze, Melissa Amber Burgess, Alice P. Chen, Ludimila Cavalcante, Emily E. Jonczak, Brian Andrew Van Tine, Steven Gore, Jonathan Fletcher, Suzanne George

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps11585

Source: Full article

---

Abstract

TPS11585